Kimberly J Popovits - Net Worth and Insider Trading

Kimberly J Popovits Net Worth

The estimated net worth of Kimberly J Popovits is at least $7 Million dollars as of 2024-11-13. Kimberly J Popovits is the President and CEO of Genomic Health Inc and owns about 116,734 shares of Genomic Health Inc (GHDX) stock worth over $7 Million. Kimberly J Popovits is also the Director of Talis Biomedical Corp and owns about 28,193 shares of Talis Biomedical Corp (TLIS) stock worth over $49,620. Details can be seen in Kimberly J Popovits's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kimberly J Popovits has not made any transactions after 2021-02-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kimberly J Popovits

To

Kimberly J Popovits Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kimberly J Popovits owns 6 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) , MyoKardia Inc (MYOK) , and 10x Genomics Inc (TXG) among others .

Click here to see the complete history of Kimberly J Popovits’s form 4 insider trades.

Insider Ownership Summary of Kimberly J Popovits

Ticker Comapny Transaction Date Type of Owner
KNSA Kiniksa Pharmaceuticals International PLC 2018-05-23 director
MYOK MyoKardia Inc 2020-06-18 director
TXG 10x Genomics Inc 2020-03-26 director
LIMIT LIMIT 2015-12-17 director
LIMIT LIMIT 2005-07-15 director
LIMIT LIMIT 2021-02-17 director

Kimberly J Popovits Latest Holdings Summary

Kimberly J Popovits currently owns a total of 2 stocks. Among these stocks, Kimberly J Popovits owns 116,734 shares of Genomic Health Inc (GHDX) as of October 8, 2019, with a value of $7 Million and a weighting of 99.33%. Kimberly J Popovits also owns 28,193 shares of Talis Biomedical Corp (TLIS) as of February 17, 2021, with a value of $49,620 and a weighting of 0.67%.

Latest Holdings of Kimberly J Popovits

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GHDX Genomic Health Inc 2019-10-08 116,734 63.44 7,405,605
TLIS Talis Biomedical Corp 2021-02-17 28,193 1.76 49,620

Holding Weightings of Kimberly J Popovits


Kimberly J Popovits Form 4 Trading Tracker

According to the SEC Form 4 filings, Kimberly J Popovits has made a total of 0 transactions in Genomic Health Inc (GHDX) over the past 5 years. The most-recent trade in Genomic Health Inc is the sale of 10,000 shares on October 8, 2019, which brought Kimberly J Popovits around $677,400.

According to the SEC Form 4 filings, Kimberly J Popovits has made a total of 1 transactions in Talis Biomedical Corp (TLIS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Talis Biomedical Corp is the acquisition of 353 shares on February 17, 2021, which cost Kimberly J Popovits around $84,800.

Insider Trading History of Kimberly J Popovits

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kimberly J Popovits Trading Performance

GuruFocus tracks the stock performance after each of Kimberly J Popovits's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kimberly J Popovits is -57.91%. GuruFocus also compares Kimberly J Popovits's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kimberly J Popovits within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kimberly J Popovits's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kimberly J Popovits

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -31.39 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -32.48 LIMIT LIMIT LIMIT LIMIT LIMIT

Kimberly J Popovits Ownership Network

Ownership Network List of Kimberly J Popovits

No Data

Ownership Network Relation of Kimberly J Popovits

Insider Network Chart

Kimberly J Popovits Owned Company Details

What does Kiniksa Pharmaceuticals International PLC do?

Who are the key executives at Kiniksa Pharmaceuticals International PLC?

Kimberly J Popovits is the director of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Business Officer Eben Tessari , and Group VP & Rilonacept GM Ross Moat .

Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary

Over the past 18 months, Kimberly J Popovits made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 309,021 shares made by Sanj K Patel , and a net sale of 52,000 shares made by Eben Tessari .

In summary, during the past 3 months, insiders sold 270,759 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 270,759 shares. During the past 18 months, 628,724 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 628,724 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiniksa Pharmaceuticals International PLC Insider Transactions

No Available Data

Kimberly J Popovits Mailing Address

Above is the net worth, insider trading, and ownership report for Kimberly J Popovits. You might contact Kimberly J Popovits via mailing address: 301 Penobscot Drive, Redwood City Ca 94063.